For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, ...
Three medications have spasticity reduction as their primary indication: baclofen (Lioresal ®), dantrolene (Dantrium ®), and tizanidine (Zanaflex ®). These drugs represent the mainstays of ...
Spasticity is a condition that affects your muscles, making them tight or stiff. This can impact your ability to perform daily activities, such as walking, eating, and talking. The condition may also ...
Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, editors. Spasticity: disordered motor control. Chicago: Year Book Medical Pubs; 1980. p. 487–9.
In cerebral palsy (CP), the spastic motor type is most common, associated with a velocity-dependent increase in muscle stiffness that precedes the development of fixed muscle contracture. In ...
Spasticity is a clinical sign characterized by muscle over-activity and high tone spasms that is associated with several distinct neurological diseases. Timely diagnosis and management are essential ...
The two mainstays of nonpharmacological spasticity management are the removal of noxious stimuli that can drive hypertonicity and the application of physical modalities. Comorbidities of neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results